Series: Competition

  2. Keynote speech by Paul Csiszár, Director of DG Competition

    Mr Paul Csiszár delivered the keynote speech concluding a high-level discussion on fair sharing and excessive prices at the intersection between competition law and regulated sectors such as pharma and telecom. In his speech, Mr Csiszár looked at the case of excessive prices of medicines from a competition law perspective.

    28 March 2023

  3. Excessive pricing in the pharmaceutical sector

    Affordable access to many drugs is made difficult by high prices. At the same time, serious questions arise about the degree of innovation and value offered by increasingly costly treatments. In this panel discussion, speakers look at the case of excessive prices of off-patent drugs and debate whether and to what extent competition authorities could also sanction excessive prices of drugs covered by patents.

    28 March 2023